TWD 60.0
(-8.95%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -37.16 Million TWD | -90.16% |
2022 | -19.54 Million TWD | -131.81% |
2021 | -8.43 Million TWD | 0.0% |
2020 | - TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -23.22 Million TWD | -90.6% |
2024 Q2 | -23.22 Million TWD | 0.0% |
2023 Q1 | -6.39 Million TWD | 11.22% |
2023 FY | -37.16 Million TWD | -90.16% |
2023 Q4 | -12.18 Million TWD | 0.0% |
2023 Q3 | -12.18 Million TWD | -90.56% |
2023 Q2 | -6.39 Million TWD | 0.0% |
2022 FY | -19.54 Million TWD | -131.81% |
2022 Q4 | -7.2 Million TWD | 0.0% |
2022 Q3 | -7.2 Million TWD | 0.0% |
2021 FY | -8.43 Million TWD | 0.0% |
2020 FY | - TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 28.228% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 114.806% |
Level Biotechnology Inc. | 62.9 Million TWD | 159.081% |
Sagittarius Life Science Corp | -55.03 Million TWD | 32.475% |
NeoCore Technology Co., Ltd. | -64.64 Million TWD | 42.509% |
TaiMed Biologics Inc. | -194.81 Million TWD | 80.922% |
GlycoNex Incorporation | -178.36 Million TWD | 79.163% |
VBI | -6.6 Million TWD | -463.021% |
GeneReach Biotechnology Corp. | -166.27 Million TWD | 77.648% |
Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -247.922% |
SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 2.638% |
Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 77.887% |
Visgeneer Inc. | -19.58 Million TWD | -89.724% |
Mycenax Biotech Inc. | -682.84 Million TWD | 94.557% |
Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 105.94% |
G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 151.333% |
Neith Corporation | -40.03 Million TWD | 7.164% |
Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 96.796% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -514.602% |
Enimmune corporation | -223.74 Million TWD | 83.389% |
TaiRx, Inc. | -212.29 Million TWD | 82.493% |
CHO Pharma, Inc. | -306.08 Million TWD | 87.858% |
EirGenix Inc. | -915.2 Million TWD | 95.939% |
BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 174.714% |
Sunny Pharmtech Inc. | -63.32 Million TWD | 41.306% |
Lin BioScience, Inc. | -687.19 Million TWD | 94.592% |
BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 76.226% |
Feng Chi Biotech Corp. | 22.79 Million TWD | 263.062% |
Bio Preventive Medicine Corp. | -73.28 Million TWD | 49.287% |
Lukas Biomedical Inc. | -47.35 Million TWD | 21.515% |
RBC Bioscience Corporation | 6.43 Million TWD | 677.994% |
BiOptic Inc. | 37.74 Million TWD | 198.458% |
BRIM Biotechnology, Inc. | -688.02 Million TWD | 94.598% |
Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 39.608% |
Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 113.523% |
Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 59.652% |
NaviFUS Corp. | -65.72 Million TWD | 43.457% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 57.81% |
Sinew Pharma Inc. | -170.92 Million TWD | 78.256% |
Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 45.473% |
Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 128.443% |
Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 84.387% |
AP Biosciences Inc | -339.29 Million TWD | 89.046% |
Medigen Biotechnology Corp. | -561.29 Million TWD | 93.379% |
3D Global Biotech Inc. | -57.95 Million TWD | 35.868% |
Pharmosa Biopharm Inc. | 8.45 Million TWD | 539.51% |
Intech Biopharm Corporation | -337.98 Million TWD | 89.004% |
Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 97.169% |
Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 27.993% |
TWi Biotechnology, Inc. | -170.68 Million TWD | 78.226% |
Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 106.89% |
TCI GENE Inc. | 11.67 Million TWD | 418.384% |
MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 70.862% |
Senhwa Biosciences, Inc. | -296.3 Million TWD | 87.457% |
Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 82.914% |
NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 467.243% |
PharmaEngine, Inc. | 274.65 Million TWD | 113.532% |
Savior Lifetec Corporation | 30.03 Million TWD | 223.76% |
TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 127.181% |
OBI Pharma, Inc. | -1.04 Billion TWD | 96.449% |
Meribank Biotech Co., Ltd | -125.34 Million TWD | 70.35% |
Acepodia, Inc. | -817.31 Million TWD | 95.453% |
Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 92.391% |